Technology, Pattern, and Policy Trio: Interpreting the New Logic of Chemical Luminescence in 2026
Release time:
2026-02-22
As the golden track in the field of in vitro diagnostics (IVD), chemiluminescence has become a standard technology in core scenarios such as tumor screening, hormone testing, and infectious disease prevention and control in clinical diagnosis due to its high sensitivity and specificity. Looking back at the timeline of 2026, China's chemiluminescence industry is experiencing a critical period of technological iteration, a period of market restructuring, and a period of policy dividends. This special stage of development has given rise to unique development characteristics and competitive logic in the industry, profoundly influencing the strategic layout of every participant in the industrial chain.

Chemiluminescence reagent
1、 Technological Upgrade: Leapfrogging from Following to Local Leading
Technological innovation has always been the core engine driving the development of the chemiluminescence industry. For a long time, the domestic market has been limited by technological barriers from overseas giants such as Roche and Abbott, and core equipment and reagents have long relied on imports. In recent years, domestic enterprises have achieved breakthroughs in key areas such as core raw material synthesis, instrument hardware design, and testing technology iteration by continuously increasing their R&D investment, gradually narrowing the gap with their brands. From traditional tube luminescence to the implementation of homogeneous chemiluminescence technology, from conventional detection to the expansion of characteristic projects, domestic technology is achieving a phased leap from "following" to "local leading", laying a solid foundation for the high-quality development of the industry.
2、 Pattern reshaping: Market competition enters a refined stage
With the deepening implementation of the graded diagnosis and treatment policy and the improvement of residents' health awareness, the demand for chemiluminescence market continues to expand, and it is expected that the market size will exceed 50 billion yuan by 2026. At the same time, there has been a fundamental shift in the logic of market competition, from the early stage of "running horses to conquer land" to the stage of refined operation of stock games. Top enterprises are accelerating channel sinking and breakthroughs in high-end markets, while small and medium-sized enterprises are focusing on segmented fields to seek differentiated development. Industry resources are constantly concentrating on enterprises with technological advantages and economies of scale, and the market pattern is being redefined.
3、 Policy driven: dual assistance of regulation and support
Accurate guidance at the policy level safeguards the development of the industry. On the one hand, the continuous promotion of the policy of centralized procurement of medical consumables has effectively reduced the cost of terminal testing, while forcing enterprises to enhance their core competitiveness; On the other hand, the implementation of policies such as prioritizing the procurement of domestic medical devices and creating a green channel for innovative medical devices has opened up convenient channels for domestic chemiluminescence products to enter medical institutions at all levels. The dual assistance of policies has not only promoted the development of the industry towards standardization and high quality, but also injected strong impetus into the process of domestic substitution.
Standing at a new starting point in 2026, China's chemiluminescence industry is experiencing a triple resonance of technological independence, pattern optimization, and policy support. In the face of this historic opportunity, only enterprises that possess core technological strength, precise market insights, and profound quality accumulation can lead the industry trend and win the long-term future.
Hubei Xindesheng, as a professional manufacturer specializing in core materials for chemiluminescence, always takes technological innovation as the engine and focuses on providing high-purity and high stability chemiluminescence substrates, detection reagents, and customized raw materials for the industry. We not only assist domestic instruments in achieving independent and controllable key raw materials, but also provide customers with integrated support from raw materials to processes based on our deep understanding of detection performance, empowering diagnostic products to improve sensitivity and stability. In the new stage of the industry moving towards "local leadership", Xindesheng is willing to work together with partners to promote the high-quality development of China's chemiluminescence industry with solid research and development strength and reliable quality commitments, injecting solid strength into the construction of a healthy China.
Previous page
Previous page
Contact details
Contact number
Address: C8, Guanggu United Science and Technology City, Ezhou City, Hubei Province
Fax:0711-3704 589
Follow us